Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial. - Jassem,J.; Pienkowski,T.; Pluzanska,A. (J Clin Oncol, 2001)